Israel's Health Ministry announced Monday that it will not broadcast a key panel discussion on the vaccination of children against coronavirus amid a "violence discourse that is liable to affect the discussion."
Instead, the conclusions of the debate on approving the Pfizer-BioNTech vaccine for five to 11-year-olds will be published afterward.
The virtual meetings, which commenced last week, were inspired by similar discussions conducted by the U.S.'s Food and Drug Administration (FDA) in a bid to improve transparency around the inoculation of young children.
The FDA authorized the Pfizer-BioNTech shot for emergency use among children aged five to 11 at the back end of October.
The Health Ministry’s head of public health services, Sharon Alroy-Preis, stated in the last round of discussions that Israel had no intention of forcing parents to vaccinate their children. Alroy-Preis herself was assigned a security detail by the police after she faced threats from anti-vaxxers as an outspoken proponent of vaccinating children.
Already ahead of the launch of the virtual panel, the Health Ministry warned that "slander of the members of the pandemic's management team...or employees of the Health Ministry will not be allowed. Verbal violence of any type will not be allowed during the discussion." Those who violate this rule will be "immediately stopped" during their presentation.
The Health Ministry reported 162 serious COVID cases on Monday, the lowest figure since the end of July. Of the serious cases, 118 are in critical condition, including 105 who are on ventilators.
The R number – the number of people each COVID carrier infects – rose last week to 0.87, up from 0.73. Despite the rise, Health Ministry data continues to suggest that the pandemic in Israel is receding.
Click the alert icon to follow topics:
"discourse" - Google News
November 09, 2021 at 01:04AM
https://ift.tt/31Byh21
Israel cancels panel livestream on kids' COVID vaccines amid 'violent discourse' - Haaretz
"discourse" - Google News
https://ift.tt/2KZL2bm
https://ift.tt/2z7DUH4
No comments:
Post a Comment